bluuebunny/crossref_metadata_2025 huggingface dataset:
Figure S4 from Oxygen-Enhanced Optoacoustic Tomography Reveals the Effectiveness of Targeting Heme and Oxidative Phosphorylation at Normalizing Tumor Vascular Oxygenation
Authors: Ghosh Poorva , Guo Yihang , Ashrafi Adnin , Chen Jingyu , Dey Sanchareeka , Zhong Shigen , Liu Jie , Campbell James , Konduri Purna Chaitanya , Gerberich Jeni , Garrossian Massoud , Mason Ralph P. , Zhang Li , Liu Li
Published: April 2023

Fig. S4. MSOT images from control and HSP2- or CycT-treated tumors of similar size. The tumors were from the same experiment shown in Fig. 2. The quantified values for all parameters shown in Fig. 2 were not changed when tumor sizes were matched. (A) The spatial distribution of baseline deoxyhemoglobin (Hb; blue), oxyhemoglobin (HbO2; red), and total hemoglobin (THb). Maps were constructed using back-projection and spectral-unmixing overlaid on the grayscale image of the corresponding animals in each treatment group (control, HSP2 and CycT). (B) Representative tumor images of spatial distribution of baseline oxygen saturation in air. (C) Representative tumor images of spatial distribution of oxygen saturation [sO2 (O2)] after the oxygen challenge and the amplitude of signal change (Î"sO2) for each treatment group from breathing air to breathing 100% oxygen. Tumor sizes are listed in Materials and Methods. Specifically, the sizes of the three shown tumors were: Control: 176 mm3, HSP2: 158 mm3, CycT: 138 mm3.
Figure S2 from Oxygen-Enhanced Optoacoustic Tomography Reveals the Effectiveness of Targeting Heme and Oxidative Phosphorylation at Normalizing Tumor Vascular Oxygenation
Authors: Ghosh Poorva , Guo Yihang , Ashrafi Adnin , Chen Jingyu , Dey Sanchareeka , Zhong Shigen , Liu Jie , Campbell James , Konduri Purna Chaitanya , Gerberich Jeni , Garrossian Massoud , Mason Ralph P. , Zhang Li , Liu Li
Published: April 2023

Fig. S2. HSP2 and CycT did not significantly affect blood and liver functions. (A) Average red blood cell count in mice bearing subcutaneous lung tumor xenografts treated with or without HSP2 or CycT. (B) Average hemoglobin levels in mice treated with or without HSP2 or CycT. (C) Average serum ALT (alanine transaminase) levels treated with or without HSP2 or CycT. (D) ATP levels measured in cells from livers excised from mice treated with HSP2, CycT, or control saline. Data are plotted as mean {plus minus} SD. For statistical analysis, the levels in treated mice were compared to the levels in untreated mice with a Welch 2-sample t-test.
Figure S1 from Oxygen-Enhanced Optoacoustic Tomography Reveals the Effectiveness of Targeting Heme and Oxidative Phosphorylation at Normalizing Tumor Vascular Oxygenation
Authors: Ghosh Poorva , Guo Yihang , Ashrafi Adnin , Chen Jingyu , Dey Sanchareeka , Zhong Shigen , Liu Jie , Campbell James , Konduri Purna Chaitanya , Gerberich Jeni , Garrossian Massoud , Mason Ralph P. , Zhang Li , Liu Li
Published: April 2023

Fig. S1. HSP2 effectively suppresses the growth, oxygen consumption rates, and ATP generation in subcutaneous A549-luc NSCLC tumor xenografts. (A) Sizes of H1299 tumors (mm3) from mice treated with HSP2 for 1.5 weeks (mid-point) or treated with HSP2/CycT for 3 weeks (end-point). (B) Photos showing excised tumors from NOD SCID mice treated with saline (control) or HSP2 (25 mg/kg I.V every 3 days) for 3 weeks (n=4/group). (B) Average weights for control and treated tumors shown in A. (C) Average body weights of control and treated mice bearing tumors shown in A. (D) Oxygen consumption rates (OCRs) measured in cells from control and treated tumors. (E) ATP levels measured in cells from control and treated tumors. Data are plotted as mean {plus minus} SEM. For statistical analysis, the levels in treated tumors were compared to the levels in control tumors with a Welch 2-sample t-test. *, P < 0.05.
Supplementary Data from Activation of β-Catenin Cooperates with Loss of Pten to Drive AR-Independent Castration-Resistant Prostate Cancer
Authors: Patel Rachana , Brzezinska Elspeth A. , Repiscak Peter , Ahmad Imran , Mui Ernest , Gao Meiling , Blomme Arnaud , Harle Victoria , Tan Ee Hong , Malviya Gaurav , Mrowinska Agata , Loveridge Carolyn J. , Rushworth Linda K. , Edwards Joanne , Ntala Chara , Nixon Colin , Hedley Ann , Mackay Gillian , Tardito Saverio , Sansom Owen J. , Leung Hing Y.
Published: April 2023

The supplementary file contains details of the materials and methods used in the manuscript. File also contains supplementary figures S1 to S3 describing in details the murine model used to study role of activated ÃŸ-catenin in prostate cancer progression. Supplementary figure S4 describes the murine orthograft model generated to study mechanistic details. Supplementary figure S5 describes the metabolic profile of primary murine prostate cancer cells with Pten loss and ÃŸ-catenin activation and figures S6 and S7 show the effects of combining ADT with inhibition of WNT signalling.
Marker selection from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
Authors: Hebert Jess D. , Myers Samuel A. , Naba Alexandra , Abbruzzese Genevieve , Lamar John M. , Carr Steven A. , Hynes Richard O.
Published: April 2023

Marker selection analysis to identify proteins elevated in each metastatic tissue
Supplementary Figure5 from Differential Contributions of Pre- and Post-EMT Tumor Cells in Breast Cancer Metastasis
Authors: Lourenco Ana Rita , Ban Yi , Crowley Michael J. , Lee Sharrell B. , Ramchandani Divya , Du Wei , Elemento Olivier , George Jason T. , Jolly Mohit Kumar , Levine Herbert , Sheng Jianting , Wong Stephen T. , Altorki Nasser K. , Gao Dingcheng
Published: April 2023

Proangiogenic function of post-EMT tumor cells.
Supplementary Figure4 from Differential Contributions of Pre- and Post-EMT Tumor Cells in Breast Cancer Metastasis
Authors: Lourenco Ana Rita , Ban Yi , Crowley Michael J. , Lee Sharrell B. , Ramchandani Divya , Du Wei , Elemento Olivier , George Jason T. , Jolly Mohit Kumar , Levine Herbert , Sheng Jianting , Wong Stephen T. , Altorki Nasser K. , Gao Dingcheng
Published: April 2023

Characterization of the Tri-PyMT primary tumor.
Supplementary Figure3 from Differential Contributions of Pre- and Post-EMT Tumor Cells in Breast Cancer Metastasis
Authors: Lourenco Ana Rita , Ban Yi , Crowley Michael J. , Lee Sharrell B. , Ramchandani Divya , Du Wei , Elemento Olivier , George Jason T. , Jolly Mohit Kumar , Levine Herbert , Sheng Jianting , Wong Stephen T. , Altorki Nasser K. , Gao Dingcheng
Published: April 2023

The scRNA-seq analysis of Tri-PyMT cells from primary tumors.
Supplementary tables S1-S3 from ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a “Toggle Switch” of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells
Authors: Almairac Fabien , Turchi Laurent , Sakakini Nathalie , Debruyne David Nicolas , Elkeurti Sarah , Gjernes Elisabet , Polo Beatrice , Bianchini Laurence , Fontaine Denys , Paquis Philippe , Chneiweiss Herve , Junier Marie-Pierre , Verrando Patrick , Burel-Vandenbos Fanny , Virolle Thierry
Published: April 2023

tables describing OCT4 and NANOG positive cells (sup table S1); tables describing gene clustering and GEO (sup tables S2 and S3)
Supplementary Data from ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a “Toggle Switch” of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells
Authors: Almairac Fabien , Turchi Laurent , Sakakini Nathalie , Debruyne David Nicolas , Elkeurti Sarah , Gjernes Elisabet , Polo Beatrice , Bianchini Laurence , Fontaine Denys , Paquis Philippe , Chneiweiss Herve , Junier Marie-Pierre , Verrando Patrick , Burel-Vandenbos Fanny , Virolle Thierry
Published: April 2023

These figures describe egfr expression and amplification in the original tumors and patient-derived GSC (sup fig 1); spheroid formation (sup fig 2); magnification of figure 1b (sup fig 3), stem-like and tumorigenic properties of the resulting spheroids (sup fig 4).
Supplementary Data from Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease
Authors: Gromisch Christopher , Qadan Motaz , Machado Mariana Albuquerque , Liu Kebin , Colson Yolonda , Grinstaff Mark W.
Published: April 2023

Additional Figures
Figure S1 from Integrin β4–Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis
Authors: Ruan Shasha , Lin Ming , Zhu Yong , Lum Lawrence , Thakur Archana , Jin Runming , Shao Wenlong , Zhang Yalei , Hu Yangyang , Huang Shiang , Hurt Elaine M. , Chang Alfred E. , Wicha Max S. , Li Qiao
Published: April 2023

Figure S1 indicated that ITGB4-targeted cancer immunotherapies did not cause severe immunotherapy-related toxicity.
Figure S1-S6, Table S1-S2 from A Small-Molecule Inhibitor Targeting TRIP13 Suppresses Multiple Myeloma Progression
Authors: Wang Yingcong , Huang Jing , Li Bo , Xue Han , Tricot Guido , Hu Liangning , Xu Zhijian , Sun Xiaoxiang , Chang Shuaikang , Gao Lu , Tao Yi , Xu Hongwei , Xie Yongsheng , Xiao Wenqin , Yu Dandan , Kong Yuanyuan , Chen Gege , Sun Xi , Lian Fulin , Zhang Naixia , Wu Xiaosong , Mao Zhiyong , Zhan Fenghuang , Zhu Weiliang , Shi Jumei
Published: April 2023

Supplementary Data descripted that DCZ0415 suppresses multiple myeloma progression via targeting TRIP13
Supplementary Data from Towards Multidrug Adaptive Therapy
Authors: West Jeffrey , You Li , Zhang Jingsong , Gatenby Robert A. , Brown Joel S. , Newton Paul K. , Anderson Alexander R.A.
Published: April 2023

Figure S1, Tables S1, S2. Table S1: Competition parameters for Lupron and Abiraterone treatment; Table S2: Competition parameters for no treatment; Figure S1: After-action analysis of patient-specific subpopulations Normalized subpopulations over time (equation 4) for testosterone-dependent (T+, yellow), testosterone-producing (TP, blue), and testosterone-independent cells (T-, green). Timing of treatment received under clinical protocol is indicated (top) for Lupron & Abiraterone (red) and Lupron only (blue). Parameterization of the model is performed by least-squares fit to PSA data from clinical trial NCT02415621 (see figure 3).
Supplementary Tables from Epigenetic SMAD3 Repression in Tumor-Associated Fibroblasts Impairs Fibrosis and Response to the Antifibrotic Drug Nintedanib in Lung Squamous Cell Carcinoma
Authors: Ikemori Rafael , Gabasa Marta , Duch Paula , Vizoso Miguel , Bragado Paloma , Arshakyan Marselina , Luis Iuliana-Cristiana , Marín Albert , Morán Sebastian , Castro Manuel , Fuster Gemma , Gea-Sorli Sabrina , Jauset Toni , Soucek Laura , Montuenga Luis M. , Esteller Manel , Monsó Eduard , Peinado Victor Ivo , Gascon Pere , Fillat Cristina , Hilberg Frank , Reguart Noemí , Alcaraz Jordi
Published: April 2023

Supplementary Tables
Supplementary Figures from Long Noncoding RNA TINCR-Mediated Regulation of Acetyl-CoA Metabolism Promotes Nasopharyngeal Carcinoma Progression and Chemoresistance
Authors: Zheng Zi-Qi , Li Zhi-Xuan , Guan Jia-Li , Liu Xu , Li Jun-Yan , Chen Yue , Lin Li , Kou Jia , Lv Jia-Wei , Zhang Lu-Lu , Zhou Guan-Qun , Liu Rui-Qi , Chen FoPing , He Xiao-Jun , Li Ying-Qin , Li Feng , Xu Si-Si , Ma Jun , Liu Na , Sun Ying
Published: April 2023

Supplemental Figure S1. TINCR is upregulated in six other cancer types. Supplemental Figure S2. GSEA analyses results of TINCR silencing. Supplemental Figure S3. Overexpression of TINCR promotes NPC cell proliferation, metastasis and cisplatin resistance in vitro. Supplemental Figure S4. Overexpression of TINCR reverses the suppressive effects of TINCR knockdown on cell proliferation, cisplatin resistance and metastasis. Supplemental Figure S5. TINCR targets ACLY and impairs its ubiquitination degradation. Supplemental Figure S6. Silencing TINCR has no effects on the expressions of KAT3A and KAT3B. Supplemental Figure S7. The ACLY-binding motif CUGKR is critical for the role of TINCR in maintaining ACLY protein stability and lipid synthesis levels. Supplemental Figure S8. Acetyl-CoA is responsible for TINCR-mediated NPC progression and chemoresistance. Supplemental Figure S9. Correlation between TINCR and PADI1 expression in 16 other cancer types from the TCGA database. Supplemental Figure S10. Silencing TINCR decreases the proteolytic activities of MMP2/9, but had no effects on H3K27ac levels at MMP2/9 promoters. Supplemental Figure S11. IGFBP3 is overexpressed in NPC
Table S1-3 from CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma
Authors: Morita Toshihiro , Kodama Yuzo , Shiokawa Masahiro , Kuriyama Katsutoshi , Marui Saiko , Kuwada Takeshi , Sogabe Yuko , Matsumori Tomoaki , Kakiuchi Nobuyuki , Tomono Teruko , Mima Atsushi , Ueda Tatsuki , Tsuda Motoyuki , Yamauchi Yuki , Nishikawa Yoshihiro , Sakuma Yojiro , Ota Yuji , Maruno Takahisa , Uza Norimitsu , Nagasawa Takashi , Chiba Tsutomu , Seno Hiroshi
Published: April 2023

table S1 : recombination detection primers and qPCR primers. tableS2 : antibodies for immunohistochemistory and two chamber assay. tableS3 : list of PDAC patients
Figure S7 from CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma
Authors: Morita Toshihiro , Kodama Yuzo , Shiokawa Masahiro , Kuriyama Katsutoshi , Marui Saiko , Kuwada Takeshi , Sogabe Yuko , Matsumori Tomoaki , Kakiuchi Nobuyuki , Tomono Teruko , Mima Atsushi , Ueda Tatsuki , Tsuda Motoyuki , Yamauchi Yuki , Nishikawa Yoshihiro , Sakuma Yojiro , Ota Yuji , Maruno Takahisa , Uza Norimitsu , Nagasawa Takashi , Chiba Tsutomu , Seno Hiroshi
Published: April 2023

Immunohistochemistry for CXCR4 and AE1/AE3 with human PDAC specimens
Figure S1 from CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma
Authors: Morita Toshihiro , Kodama Yuzo , Shiokawa Masahiro , Kuriyama Katsutoshi , Marui Saiko , Kuwada Takeshi , Sogabe Yuko , Matsumori Tomoaki , Kakiuchi Nobuyuki , Tomono Teruko , Mima Atsushi , Ueda Tatsuki , Tsuda Motoyuki , Yamauchi Yuki , Nishikawa Yoshihiro , Sakuma Yojiro , Ota Yuji , Maruno Takahisa , Uza Norimitsu , Nagasawa Takashi , Chiba Tsutomu , Seno Hiroshi
Published: April 2023

Cxcr4 is not essential for pancreatic development.
Supplementary Data from Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non–Small Cell Lung Cancer
Authors: Li Fei , Ng Wai-Lung , Luster Troy A. , Hu Hai , Sviderskiy Vladislav O. , Dowling Catríona M. , Hollinshead Kate E.R. , Zouitine Paula , Zhang Hua , Huang Qingyuan , Ranieri Michela , Wang Wei , Fang Zhaoyuan , Chen Ting , Deng Jiehui , Zhao Kai , So Hon-Cheong , Khodadadi-Jamayran Alireza , Xu Mousheng , Karatza Angeliki , Pyon Val , Li Shuai , Pan Yuanwang , Labbe Kristen , Almonte Christina , Poirier John T. , Miller George , Possemato Richard , Qi Jun , Wong Kwok-Kin
Published: April 2023

12 supplementary figures
Supplementary Figure S5 from BACH1 Promotes Pancreatic Cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial–Mesenchymal Transition
Authors: Sato Masaki , Matsumoto Mitsuyo , Saiki Yuriko , Alam Mahabub , Nishizawa Hironari , Rokugo Masahiro , Brydun Andrey , Yamada Shinji , Kaneko Mika K. , Funayama Ryo , Ito Mamoru , Kato Yukinari , Nakayama Keiko , Unno Michiaki , Igarashi Kazuhiko
Published: April 2023

Induction of epithelial gene expression in AsPC1 cells lacking BACH1. Details are described in methods and legends file (Supplementary_methods_and_legends).
Figure S4 from Normal Breast-Derived Epithelial Cells with Luminal and Intrinsic Subtype-Enriched Gene Expression Document Interindividual Differences in Their Differentiation Cascade
Authors: Kumar Brijesh , Prasad Mayuri , Bhat-Nakshatri Poornima , Anjanappa Manjushree , Kalra Maitri , Marino Natascia , Storniolo Anna Maria , Rao Xi , Liu Sheng , Wan Jun , Liu Yunlong , Nakshatri Harikrishna
Published: April 2023

KTB cell lines form mammospheres, which show variable levels of differentiation
Table S2 from A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability
Authors: Leoni Guido , D'Alise Anna Morena , Cotugno Gabriella , Langone Francesca , Garzia Irene , De Lucia Maria , Fichera Imma , Vitale Rosa , Bignone Veronica , Tucci Fabio Giovanni , Mori Federica , Leuzzi Adriano , Di Matteo Elena , Troise Fulvia , Abbate Adele , Merone Rossella , Ruzza Valentino , Diodoro Maria Grazia , Yadav Mahesh , Gordon-Alonso Monica , Vanhaver Cristophe , Panigada Maddalena , Soprana Elisa , Siccardi Antonio , Folgori Antonella , Colloca Stefano , van der Bruggen Pierre , Nicosia Alfredo , Lahm Armin , Catanese Maria Teresa , Scarselli Elisa
Published: April 2023

Top Nous-209-derived peptides predicted to bind to HLA-A*02:01.
Figure S3 from Obesity/Type 2 Diabetes-Associated Liver Tumors Are Sensitive to Cyclin D1 Deficiency
Authors: Luo Chi , Liang Jiaxin , Sharabi Kfir , Hatting Maximilian , Perry Elizabeth A. , Tavares Clint D.J. , Goyal Lipika , Srivastava Amitabh , Bilodeau Marc , Zhu Andrew X. , Sicinski Piotr , Puigserver Pere
Published: April 2023

Metabolic and inflammatory parameters of the DEN-treatment mice
Figure S2 from Obesity/Type 2 Diabetes-Associated Liver Tumors Are Sensitive to Cyclin D1 Deficiency
Authors: Luo Chi , Liang Jiaxin , Sharabi Kfir , Hatting Maximilian , Perry Elizabeth A. , Tavares Clint D.J. , Goyal Lipika , Srivastava Amitabh , Bilodeau Marc , Zhu Andrew X. , Sicinski Piotr , Puigserver Pere
Published: April 2023

Deletion of Cyclin D1 in hepatocytes does not alter the mouse metabolic responses.
Supplementary Tables from The D2 and D3 Sublineages of Human Papilloma Virus 16–Positive Cervical Cancer in Guatemala Differ in Integration Rate and Age of Diagnosis
Authors: Lou Hong , Boland Joseph F. , Torres-Gonzalez Edmundo , Albanez Anaseidy , Zhou Weiyin , Steinberg Mia K. , Diaw Lena , Mitchell Jason , Roberson David , Cullen Michael , Garland Lisa , Bass Sara , Burk Robert D. , Yeager Meredith , Wentzensen Nicolas , Schiffman Mark , Freites Enrique Alvirez , Gharzouzi Eduardo , Mirabello Lisa , Dean Michael
Published: April 2023

Supplementary tables 1-7
Supplementary Data from The Synthetic Small Molecule FL3 Combats Intestinal Tumorigenesis via Axin1-Mediated Inhibition of Wnt/β-Catenin Signaling
Authors: Jackson Dakota N. , Alula Kibrom M. , Delgado-Deida Yaritza , Tabti Redouane , Turner Kevin , Wang Xuan , Venuprasad K. , Souza Rhonda F. , Désaubry Laurent , Theiss Arianne L.
Published: April 2023

Inhibition of Wnt/β-catenin by FL3 is prevented by S45 deletion
Supplementary Data from The Synthetic Small Molecule FL3 Combats Intestinal Tumorigenesis via Axin1-Mediated Inhibition of Wnt/β-Catenin Signaling
Authors: Jackson Dakota N. , Alula Kibrom M. , Delgado-Deida Yaritza , Tabti Redouane , Turner Kevin , Wang Xuan , Venuprasad K. , Souza Rhonda F. , Désaubry Laurent , Theiss Arianne L.
Published: April 2023

FL3 does not decrease viability in IEC6 cells compared to standard CRC chemotherapeutic drugs.
Supplementary Data from The Synthetic Small Molecule FL3 Combats Intestinal Tumorigenesis via Axin1-Mediated Inhibition of Wnt/β-Catenin Signaling
Authors: Jackson Dakota N. , Alula Kibrom M. , Delgado-Deida Yaritza , Tabti Redouane , Turner Kevin , Wang Xuan , Venuprasad K. , Souza Rhonda F. , Désaubry Laurent , Theiss Arianne L.
Published: April 2023

In vivo cell proliferation and GI histology are not altered by FL3
Figure S1 from Chemotherapy-Induced Upregulation of Small Extracellular Vesicle-Associated PTX3 Accelerates Breast Cancer Metastasis
Authors: Wills Carson A. , Liu Xiaoming , Chen Longgui , Zhao Yuanjun , Dower Christopher M. , Sundstrom Jeffrey , Wang Hong-Gang
Published: April 2023

Doxorubicin treatment accelerates breast cancer metastasis.
Supplementary Data from Optimal Timing for Cancer Screening and Adaptive Surveillance Using Mathematical Modeling
Authors: Curtius Kit , Dewanji Anup , Hazelton William D. , Rubenstein Joel H. , Luebeck Georg E.
Published: April 2023

Figure S1, Table S1, and Supplementary Methods 3.1-3.10
Supplementary Figure 1 from Radiomic Detection of EGFR Mutations in NSCLC
Authors: Rossi Giovanni , Barabino Emanuele , Fedeli Alessandro , Ficarra Gianluca , Coco Simona , Russo Alessandro , Adamo Vincenzo , Buemi Francesco , Zullo Lodovica , Dono Mariella , De Luca Giuseppa , Longo Luca , Dal Bello Maria Giovanna , Tagliamento Marco , Alama Angela , Cittadini Giuseppe , Pronzato Paolo , Genova Carlo
Published: April 2023

Supplementary Figure 1
Supplementary Figure S9 from YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver Tumorigenesis
Authors: Thomann Stefan , Weiler Sofia M.E. , Marquard Simone , Rose Fabian , Ball Claudia R. , Tóth Marcell , Wei Teng , Sticht Carsten , Fritzsche Sarah , Roessler Stephanie , De La Torre Carolina , Ryschich Eduard , Ermakova Olga , Mogler Carolin , Kazdal Daniel , Gretz Norbert , Glimm Hanno , Rempel Eugen , Schirmacher Peter , Breuhahn Kai
Published: April 2023

Hgf/c-Met signaling supports migration of cells with CEC phenotype
Supplementary Figure S6 from YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver Tumorigenesis
Authors: Thomann Stefan , Weiler Sofia M.E. , Marquard Simone , Rose Fabian , Ball Claudia R. , Tóth Marcell , Wei Teng , Sticht Carsten , Fritzsche Sarah , Roessler Stephanie , De La Torre Carolina , Ryschich Eduard , Ermakova Olga , Mogler Carolin , Kazdal Daniel , Gretz Norbert , Glimm Hanno , Rempel Eugen , Schirmacher Peter , Breuhahn Kai
Published: April 2023

Perturbation of cellular communication blocks CEC expansion
Supplementary Figure S4 from YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver Tumorigenesis
Authors: Thomann Stefan , Weiler Sofia M.E. , Marquard Simone , Rose Fabian , Ball Claudia R. , Tóth Marcell , Wei Teng , Sticht Carsten , Fritzsche Sarah , Roessler Stephanie , De La Torre Carolina , Ryschich Eduard , Ermakova Olga , Mogler Carolin , Kazdal Daniel , Gretz Norbert , Glimm Hanno , Rempel Eugen , Schirmacher Peter , Breuhahn Kai
Published: April 2023

Dynamic EC subpopulation changes in liver tumor models
Supplementary Figure S11 from YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver Tumorigenesis
Authors: Thomann Stefan , Weiler Sofia M.E. , Marquard Simone , Rose Fabian , Ball Claudia R. , Tóth Marcell , Wei Teng , Sticht Carsten , Fritzsche Sarah , Roessler Stephanie , De La Torre Carolina , Ryschich Eduard , Ermakova Olga , Mogler Carolin , Kazdal Daniel , Gretz Norbert , Glimm Hanno , Rempel Eugen , Schirmacher Peter , Breuhahn Kai
Published: April 2023

Confirmatory data for OPN and HGF in samples derived from human HCC patients.
Supplementary Figure S1 from YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver Tumorigenesis
Authors: Thomann Stefan , Weiler Sofia M.E. , Marquard Simone , Rose Fabian , Ball Claudia R. , Tóth Marcell , Wei Teng , Sticht Carsten , Fritzsche Sarah , Roessler Stephanie , De La Torre Carolina , Ryschich Eduard , Ermakova Olga , Mogler Carolin , Kazdal Daniel , Gretz Norbert , Glimm Hanno , Rempel Eugen , Schirmacher Peter , Breuhahn Kai
Published: April 2023

Morphological and functional characterization of hepatic EC heterogeneity
Figure S8 from Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas
Authors: Lenkiewicz Elizabeth , Malasi Smriti , Hogenson Tara L. , Flores Luis F. , Barham Whitney , Phillips William J. , Roesler Alexander S. , Chambers Kendall R. , Rajbhandari Nirakar , Hayashi Akimasa , Antal Corina E. , Downes Michael , Grandgenett Paul M. , Hollingsworth Michael A. , Cridebring Derek , Xiong Yuning , Lee Jeong-Heon , Ye Zhenqing , Yan Huihuang , Hernandez Matthew C. , Leiting Jennifer L. , Evans Ronald M. , Ordog Tamas , Truty Mark J. , Borad Mitesh J. , Reya Tannishtha , Von Hoff Daniel D. , Fernandez-Zapico Martin E. , Barrett Michael T.
Published: April 2023

IHC analysis of RORC in ASCP PDXs and metastases. A) PAX265; B) PAX139; C) 9R liver metastases; D) Summary of RORC staining in PDAC and ASCP primary PDXs, and in metastatic lesions (+ low predominately cytosolic, ++ medium cytosolic and nuclear, +++ high predominately nuclear).
Figure S5 from Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas
Authors: Lenkiewicz Elizabeth , Malasi Smriti , Hogenson Tara L. , Flores Luis F. , Barham Whitney , Phillips William J. , Roesler Alexander S. , Chambers Kendall R. , Rajbhandari Nirakar , Hayashi Akimasa , Antal Corina E. , Downes Michael , Grandgenett Paul M. , Hollingsworth Michael A. , Cridebring Derek , Xiong Yuning , Lee Jeong-Heon , Ye Zhenqing , Yan Huihuang , Hernandez Matthew C. , Leiting Jennifer L. , Evans Ronald M. , Ordog Tamas , Truty Mark J. , Borad Mitesh J. , Reya Tannishtha , Von Hoff Daniel D. , Fernandez-Zapico Martin E. , Barrett Michael T.
Published: April 2023

Focal amplicons in ASCP genomes. The CNV profiles of A) A129 and B) PAX232 included focal high level (log2 ratio >2) amplicons that targeted the TLK2 and the ASH2L loci respectively. The X and Y axes in the CGH plots represent chromosome and log2 ratios for each genome. Red shaded areas denote homozygous deletions.
Supplementary Figures and Legends from Dynamic Regulation of Expression of KRAS and Its Effectors Determines the Ability to Initiate Tumorigenesis in Pancreatic Acinar Cells
Authors: Assi Mohamad , Achouri Younes , Loriot Axelle , Dauguet Nicolas , Dahou Hajar , Baldan Jonathan , Libert Maxime , Fain Jean S. , Guerra Carmen , Bouwens Luc , Barbacid Mariano , Lemaigre Frédéric P. , Jacquemin Patrick
Published: April 2023

Document describing important findings related to the main manuscript.
Figure S2 from Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas
Authors: Lenkiewicz Elizabeth , Malasi Smriti , Hogenson Tara L. , Flores Luis F. , Barham Whitney , Phillips William J. , Roesler Alexander S. , Chambers Kendall R. , Rajbhandari Nirakar , Hayashi Akimasa , Antal Corina E. , Downes Michael , Grandgenett Paul M. , Hollingsworth Michael A. , Cridebring Derek , Xiong Yuning , Lee Jeong-Heon , Ye Zhenqing , Yan Huihuang , Hernandez Matthew C. , Leiting Jennifer L. , Evans Ronald M. , Ordog Tamas , Truty Mark J. , Borad Mitesh J. , Reya Tannishtha , Von Hoff Daniel D. , Fernandez-Zapico Martin E. , Barrett Michael T.
Published: April 2023

A-B) DNA content histograms and genomic profiles of flow sorted diploid only ASCP biopsies. A) female (two copies of chromosome X) and; B) male (one copy of chromosome X) diploid only ASCP biopsies. In both cases the 4.0N fractions were <6% of the sample. C) DNA content histograms of ASCP PDX models. Each sample had a mouse host (green) and at least one tumor peak (red). All PDX samples were flow sorted prior to CNV, exome, and ATAC-seq analysis.
Supplementary Table 3 from Hormonal Regulation of Semaphorin 7a in ER+ Breast Cancer Drives Therapeutic Resistance
Authors: Crump Lyndsey S. , Wyatt Garhett L. , Rutherford Taylor R. , Richer Jennifer K. , Porter Weston W. , Lyons Traci R.
Published: April 2023

Oncomine analysis for predicted drug sensitivity of SEMA7A-expressing cells
Supplementary Figure 1 from Hormonal Regulation of Semaphorin 7a in ER+ Breast Cancer Drives Therapeutic Resistance
Authors: Crump Lyndsey S. , Wyatt Garhett L. , Rutherford Taylor R. , Richer Jennifer K. , Porter Weston W. , Lyons Traci R.
Published: April 2023

SEMA7A predicts for outcome in ER+BC and SEMA7A expression is regulated by estrogen
Supplementary Figures from Nanoengineered Disruption of Heat Shock Protein 90 Targets Drug-Induced Resistance and Relieves Natural Killer Cell Suppression in Breast Cancer
Authors: Smalley Munisha , Natarajan Siva Kumar , Mondal Jayanta , Best Douglas , Goldman David , Shanthappa Basavaraja , Pellowe Moriah , Dash Chinmayee , Saha Tanmoy , Khiste Sachin , Ramadurai Nithya , Eton Elliot O. , Smalley Joshua L. , Brown Andrew , Thayakumar Allen , Rahman Mamunur , Arai Kazuya , Kohandel Mohammad , Sengupta Shiladitya , Goldman Aaron
Published: April 2023

Supplemental figures
Supplementary Table S2 from Nedd9 Restrains Autophagy to Limit Growth of Early Stage Non–Small Cell Lung Cancer
Authors: Deneka Alexander Y. , Kopp Meghan C. , Nikonova Anna S. , Gaponova Anna V. , Kiseleva Anna A. , Hensley Harvey H. , Flieder Douglas B. , Serebriiskii Ilya G. , Golemis Erica A.
Published: April 2023

Primers used for RT-PCR in study
Supplementary Table S1 from Nedd9 Restrains Autophagy to Limit Growth of Early Stage Non–Small Cell Lung Cancer
Authors: Deneka Alexander Y. , Kopp Meghan C. , Nikonova Anna S. , Gaponova Anna V. , Kiseleva Anna A. , Hensley Harvey H. , Flieder Douglas B. , Serebriiskii Ilya G. , Golemis Erica A.
Published: April 2023

Antibodies used in study
Supplementary Figure S6 from Nedd9 Restrains Autophagy to Limit Growth of Early Stage Non–Small Cell Lung Cancer
Authors: Deneka Alexander Y. , Kopp Meghan C. , Nikonova Anna S. , Gaponova Anna V. , Kiseleva Anna A. , Hensley Harvey H. , Flieder Douglas B. , Serebriiskii Ilya G. , Golemis Erica A.
Published: April 2023

Relation of NEDD9 mRNA expression and tumor stage in various cancers
Supplementary Figure S5 from Nedd9 Restrains Autophagy to Limit Growth of Early Stage Non–Small Cell Lung Cancer
Authors: Deneka Alexander Y. , Kopp Meghan C. , Nikonova Anna S. , Gaponova Anna V. , Kiseleva Anna A. , Hensley Harvey H. , Flieder Douglas B. , Serebriiskii Ilya G. , Golemis Erica A.
Published: April 2023

NEDD9 mutations and survival based on tumor size and NEDD9 expression in TCGA data
Supplementary Figure S1 from Nedd9 Restrains Autophagy to Limit Growth of Early Stage Non–Small Cell Lung Cancer
Authors: Deneka Alexander Y. , Kopp Meghan C. , Nikonova Anna S. , Gaponova Anna V. , Kiseleva Anna A. , Hensley Harvey H. , Flieder Douglas B. , Serebriiskii Ilya G. , Golemis Erica A.
Published: April 2023

Images of airspace volume
Supplementary Data from Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody–Drug Conjugate and Immune Checkpoint Blockade
Authors: Boshuizen Julia , Pencheva Nora , Krijgsman Oscar , Altimari Daniela D'Empaire , Castro Patricia Garrido , de Bruijn Beaunelle , Ligtenberg Maarten A. , Gresnigt-Van den Heuvel Elke , Vredevoogd David W. , Song Ji-Ying , Visser Nils , Apriamashvili Georgi , Janmaat Maarten L. , Plantinga Theo S. , Franken Patrick , Houtkamp Mischa , Lingnau Andreas , Jure-Kunkel Maria , Peeper Daniel S.
Published: April 2023

Supplementary Table 1 Differentially expressed genes of PCA3, comparing EnaV-treated tumors to control tumors
Figure S7 from Tumor-Derived Pericytes Driven by EGFR Mutations Govern the Vascular and Immune Microenvironment of Gliomas
Authors: Segura-Collar Berta , Garranzo-Asensio María , Herranz Beatriz , Hernández-SanMiguel Esther , Cejalvo Teresa , Casas Bárbara S. , Matheu Ander , Pérez-Núñez Ángel , Sepúlveda-Sánchez Juan Manuel , Hernández-Laín Aurelio , Palma Verónica , Gargini Ricardo , Sánchez-Gómez Pilar
Published: April 2023

PDGFRβ signaling is activated in the blood vessels of mutant EGFR gliomas and stabilized the vasculature.
Figure S5 from Tumor-Derived Pericytes Driven by EGFR Mutations Govern the Vascular and Immune Microenvironment of Gliomas
Authors: Segura-Collar Berta , Garranzo-Asensio María , Herranz Beatriz , Hernández-SanMiguel Esther , Cejalvo Teresa , Casas Bárbara S. , Matheu Ander , Pérez-Núñez Ángel , Sepúlveda-Sánchez Juan Manuel , Hernández-Laín Aurelio , Palma Verónica , Gargini Ricardo , Sánchez-Gómez Pilar
Published: April 2023

Participation of EGFR mutations in the formation of glioma-derived pericytes.
Figure S1 from Tumor-Derived Pericytes Driven by EGFR Mutations Govern the Vascular and Immune Microenvironment of Gliomas
Authors: Segura-Collar Berta , Garranzo-Asensio María , Herranz Beatriz , Hernández-SanMiguel Esther , Cejalvo Teresa , Casas Bárbara S. , Matheu Ander , Pérez-Núñez Ángel , Sepúlveda-Sánchez Juan Manuel , Hernández-Laín Aurelio , Palma Verónica , Gargini Ricardo , Sánchez-Gómez Pilar
Published: April 2023

Association between the levels of angiogenic molecules and the aggressiveness and the genetic alterations of gliomas.
Supplementary Table 4 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition
Authors: Sharbeen George , McCarroll Joshua A. , Akerman Anouschka , Kopecky Chantal , Youkhana Janet , Kokkinos John , Holst Jeff , Boyer Cyrille , Erkan Mert , Goldstein David , Timpson Paul , Cox Thomas R. , Pereira Brooke A. , Chitty Jessica L. , Fey Sigrid K. , Najumudeen Arafath K. , Campbell Andrew D. , Sansom Owen J. , Ignacio Rosa Mistica C. , Naim Stephanie , Liu Jie , Russia Nelson , Lee Julia , Chou Angela , Johns Amber , Gill Anthony J. , Gonzales-Aloy Estrella , Gebski Val , Guan Yi Fang , Pajic Marina , Turner Nigel , Apte Minoti V. , Davis Thomas P. , Morton Jennifer P. , Haghighi Koroush S. , Kasparian Jorjina , McLean Benjamin J. , Setargew Yordanos F. , Phillips Phoebe A.
Published: April 2023

SLC7A11 multivariate survival analysis parameters.
Supplementary Table 3 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition
Authors: Sharbeen George , McCarroll Joshua A. , Akerman Anouschka , Kopecky Chantal , Youkhana Janet , Kokkinos John , Holst Jeff , Boyer Cyrille , Erkan Mert , Goldstein David , Timpson Paul , Cox Thomas R. , Pereira Brooke A. , Chitty Jessica L. , Fey Sigrid K. , Najumudeen Arafath K. , Campbell Andrew D. , Sansom Owen J. , Ignacio Rosa Mistica C. , Naim Stephanie , Liu Jie , Russia Nelson , Lee Julia , Chou Angela , Johns Amber , Gill Anthony J. , Gonzales-Aloy Estrella , Gebski Val , Guan Yi Fang , Pajic Marina , Turner Nigel , Apte Minoti V. , Davis Thomas P. , Morton Jennifer P. , Haghighi Koroush S. , Kasparian Jorjina , McLean Benjamin J. , Setargew Yordanos F. , Phillips Phoebe A.
Published: April 2023

SLC7A11 expression in iCAFs, myCAFs and quiescent PSCs.
Supplementary Table 2 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition
Authors: Sharbeen George , McCarroll Joshua A. , Akerman Anouschka , Kopecky Chantal , Youkhana Janet , Kokkinos John , Holst Jeff , Boyer Cyrille , Erkan Mert , Goldstein David , Timpson Paul , Cox Thomas R. , Pereira Brooke A. , Chitty Jessica L. , Fey Sigrid K. , Najumudeen Arafath K. , Campbell Andrew D. , Sansom Owen J. , Ignacio Rosa Mistica C. , Naim Stephanie , Liu Jie , Russia Nelson , Lee Julia , Chou Angela , Johns Amber , Gill Anthony J. , Gonzales-Aloy Estrella , Gebski Val , Guan Yi Fang , Pajic Marina , Turner Nigel , Apte Minoti V. , Davis Thomas P. , Morton Jennifer P. , Haghighi Koroush S. , Kasparian Jorjina , McLean Benjamin J. , Setargew Yordanos F. , Phillips Phoebe A.
Published: April 2023

Australian Pancreatic Cancer Genome Initiative International Cancer Genome Cohort patient cohort characteristics.
Supplementary Information from Nicotine-Induced ILF2 Facilitates Nuclear mRNA Export of Pluripotency Factors to Promote Stemness and Chemoresistance in Human Esophageal Cancer
Authors: Li Yue , Wang Meng , Yang Muwen , Xiao Yunyun , Jian Yunting , Shi Dongni , Chen Xiangfu , Ouyang Ying , Kong Lingzhi , Huang Xinjian , Bai Jiewen , Hu Yameng , Lin Chuyong , Song Libing
Published: April 2023

This document contains Supplementary Materials and Methods and Supplementary Data.
Figure S3 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition
Authors: Sharbeen George , McCarroll Joshua A. , Akerman Anouschka , Kopecky Chantal , Youkhana Janet , Kokkinos John , Holst Jeff , Boyer Cyrille , Erkan Mert , Goldstein David , Timpson Paul , Cox Thomas R. , Pereira Brooke A. , Chitty Jessica L. , Fey Sigrid K. , Najumudeen Arafath K. , Campbell Andrew D. , Sansom Owen J. , Ignacio Rosa Mistica C. , Naim Stephanie , Liu Jie , Russia Nelson , Lee Julia , Chou Angela , Johns Amber , Gill Anthony J. , Gonzales-Aloy Estrella , Gebski Val , Guan Yi Fang , Pajic Marina , Turner Nigel , Apte Minoti V. , Davis Thomas P. , Morton Jennifer P. , Haghighi Koroush S. , Kasparian Jorjina , McLean Benjamin J. , Setargew Yordanos F. , Phillips Phoebe A.
Published: April 2023

SLC7A11 knockdown in PDAC CAFs does not affect glutamate secretion and is maintained in the presence of oxidative stress.
Figure S2 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition
Authors: Sharbeen George , McCarroll Joshua A. , Akerman Anouschka , Kopecky Chantal , Youkhana Janet , Kokkinos John , Holst Jeff , Boyer Cyrille , Erkan Mert , Goldstein David , Timpson Paul , Cox Thomas R. , Pereira Brooke A. , Chitty Jessica L. , Fey Sigrid K. , Najumudeen Arafath K. , Campbell Andrew D. , Sansom Owen J. , Ignacio Rosa Mistica C. , Naim Stephanie , Liu Jie , Russia Nelson , Lee Julia , Chou Angela , Johns Amber , Gill Anthony J. , Gonzales-Aloy Estrella , Gebski Val , Guan Yi Fang , Pajic Marina , Turner Nigel , Apte Minoti V. , Davis Thomas P. , Morton Jennifer P. , Haghighi Koroush S. , Kasparian Jorjina , McLean Benjamin J. , Setargew Yordanos F. , Phillips Phoebe A.
Published: April 2023

Anti-proliferative effect of SLC7A11 knockdown in CAFs and the effect of SLC7A11 inhibition in MiaPaCa-2 PDAC cells and normal human pancreatic ductal epithelial (HPDE) cells.
Supplementary Tables 1-5 from SNAI2-Mediated Repression of BIM Protects Rhabdomyosarcoma from Ionizing Radiation
Authors: Wang Long , Hensch Nicole R. , Bondra Kathryn , Sreenivas Prethish , Zhao Xiang R. , Chen Jiangfei , Moreno Campos Rodrigo , Baxi Kunal , Vaseva Angelina V. , Sunkel Benjamin D. , Gryder Berkley E. , Pomella Silvia , Stanton Benjamin Z. , Zheng Siyuan , Chen Eleanor Y. , Rota Rossella , Khan Javed , Houghton Peter J. , Ignatius Myron S.
Published: April 2023

Supplemental Tables 1-5
Supplementary Material from A Transcriptionally Distinct Subpopulation of Healthy Acinar Cells Exhibit Features of Pancreatic Progenitors and PDAC
Authors: Gopalan Vishaka , Singh Arashdeep , Rashidi Mehrabadi Farid , Wang Li , Ruppin Eytan , Arda H. Efsun , Hannenhalli Sridhar
Published: April 2023

Contains Supplementary Sections S1-S4 and Supplementary Figures S1-S3.
Table S4 from Epstein–Barr Virus–Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1
Authors: Ge Junshang , Wang Jie , Xiong Fang , Jiang Xianjie , Zhu Kunjie , Wang Yian , Mo Yongzhen , Gong Zhaojian , Zhang Shanshan , He Yi , Li Xiayu , Shi Lei , Guo Can , Wang Fuyan , Zhou Ming , Xiang Bo , Li Yong , Li Guiyuan , Xiong Wei , Zeng Zhaoyang
Published: April 2023

List of antibodies for immunohistochemistry, western blotting, immunofluorescence, flow cytometry, RNA pulldown, and ChIP experiments.
Table S2 from Epstein–Barr Virus–Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1
Authors: Ge Junshang , Wang Jie , Xiong Fang , Jiang Xianjie , Zhu Kunjie , Wang Yian , Mo Yongzhen , Gong Zhaojian , Zhang Shanshan , He Yi , Li Xiayu , Shi Lei , Guo Can , Wang Fuyan , Zhou Ming , Xiang Bo , Li Yong , Li Guiyuan , Xiong Wei , Zeng Zhaoyang
Published: April 2023

Clinicopathological data for 52 paraffin-embedded NPC tissues and 36 non-cancerous NPE samples using in situ hybridization or immunohistochemistry.
Supplementary Table S3 from Genetic Variation and Recurrent Haplotypes on Chromosome 6q23-25 Risk Locus in Familial Lung Cancer
Authors: Musolf Anthony M. , Simpson Claire L. , Moiz Bilal A. , Pikielny Claudio W. , Middlebrooks Candace D. , Mandal Diptasri , de Andrade Mariza , Cole Michael D. , Gaba Colette , Yang Ping , You Ming , Li Yafang , Kupert Elena Y. , Anderson Marshall W. , Schwartz Ann G. , Pinney Susan M. , Amos Christopher I. , Bailey-Wilson Joan E.
Published: April 2023

Regional LOD scores of haplotypes
Supplementary Figure S5 from Genetic Variation and Recurrent Haplotypes on Chromosome 6q23-25 Risk Locus in Familial Lung Cancer
Authors: Musolf Anthony M. , Simpson Claire L. , Moiz Bilal A. , Pikielny Claudio W. , Middlebrooks Candace D. , Mandal Diptasri , de Andrade Mariza , Cole Michael D. , Gaba Colette , Yang Ping , You Ming , Li Yafang , Kupert Elena Y. , Anderson Marshall W. , Schwartz Ann G. , Pinney Susan M. , Amos Christopher I. , Bailey-Wilson Joan E.
Published: April 2023

Supplementary Figure S5: Segregation of potential causal variants in UTRN and PHACTR2 in families 30, 33 and 35. In all pedigrees, gray symbols represent non-affected individuals (coded as missing in the analysis) and black symbol represent affected individuals. The diagonal slash through the symbol represents a deceased individual and brackets around an individual's ID represents individuals who were sequenced. A) Family 30 pedigree with the first two letters underneath the individual ID represents the individual's genotype at rs186871831 (major allele = C, minor allele = T) and the second two letters underneath the individual ID represents the individual's genotype at rs966382235 (major allele = C, minor allele = T) B) Family 33 pedigree with the first two letters underneath the individual ID represents the individual's genotype at rs532363235 (major allele = A, minor allele = G) and the second two letters underneath the individual ID represents the individual's genotype at rs79313503 (major allele = G, minor allele = A) C) Family 33 pedigree with the first two letters underneath the individual ID represents the individual's genotype at rs191491353 (major allele = C, minor allele = A) and the second two letters underneath the individual ID represents the individual's genotype at rs553447284 (major allele = A, minor allele = T).
Supplementary Figure S1 from Genetic Variation and Recurrent Haplotypes on Chromosome 6q23-25 Risk Locus in Familial Lung Cancer
Authors: Musolf Anthony M. , Simpson Claire L. , Moiz Bilal A. , Pikielny Claudio W. , Middlebrooks Candace D. , Mandal Diptasri , de Andrade Mariza , Cole Michael D. , Gaba Colette , Yang Ping , You Ming , Li Yafang , Kupert Elena Y. , Anderson Marshall W. , Schwartz Ann G. , Pinney Susan M. , Amos Christopher I. , Bailey-Wilson Joan E.
Published: April 2023

Supplementary Figure S1: Collapsed haplotype pattern (CHP) analysis across all 9 families. The heterogeneity LOD (HLOD) scores of the regional CHP analysis. The line at 3.3 represents the line for genome-wide significance based on Lander and Kruglyak.
Supplementary Data from Oxidized Low-Density Lipoprotein Links Hypercholesterolemia and Bladder Cancer Aggressiveness by Promoting Cancer Stemness
Authors: Yang Lin , Sun Jingya , Li Meiqian , Long Yiming , Zhang Dianzheng , Guo Hongqian , Huang Ruimin , Yan Jun
Published: April 2023

Supplementary Materials and Methods, Figures and Tables
Supplementary Figure Legends from Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non–Small Cell Lung Cancer
Authors: Li Rui , Salehi-Rad Ramin , Crosson William , Momcilovic Milica , Lim Raymond J. , Ong Stephanie L. , Huang Zi Ling , Zhang Tianhao , Abascal Jensen , Dumitras Camelia , Jing Zhe , Park Stacy J. , Krysan Kostyantyn , Shackelford David B. , Tran Linh M. , Liu Bin , Dubinett Steven M.
Published: April 2023

Supplemental Figure Legends S1-S6
Supplemental Figure 5 from PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy
Authors: Chekaoui Arezki , Ertl Hildegund C.J.
Published: April 2023

The cartoon describes the experimental set-up used to generate the results shown in Figures 4A and C. Mice were challenged with tumor cells. They were not vaccinated. Starting 8 days after challenge they were treated for 3 weeks with fenofibrate or diluent. Mice were euthanized ~24 hours later to analyze sera, the tumor interstitial fluids and cells within the tumors.
Supplemental Figure 4 from PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy
Authors: Chekaoui Arezki , Ertl Hildegund C.J.
Published: April 2023

A The cartoon describes the experimental set-up. B shows frequencies of Trp-1-tet+ CD8+ in spleens and tumors. To better compare cells from naïve and vaccinated mice we gated on naïve cells (CD62Lhi), recently activated cells (PD1high,CD62Llow), tetramer+CD8+ T cells over all CD8 T cells or tetramer+ CD8+ T cells over all recently activated PD1high,CD62Llow CD8+ T cells. C shows phenotypes of percentages of marker positive cells.
Supplementary Table 9 from Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1–Mediated Secretion of Extracellular Vesicles
Authors: Grunberg Nil , Pevsner-Fischer Meirav , Goshen-Lago Tal , Diment Judith , Stein Yaniv , Lavon Hagar , Mayer Shimrit , Levi-Galibov Oshrat , Friedman Gil , Ofir-Birin Yifat , Syu Li-Jyun , Migliore Cristina , Shimoni Eyal , Stemmer Salomon M. , Brenner Baruch , Dlugosz Andrzej A. , Lyden David , Regev-Rudzki Neta , Ben-Aharon Irit , Scherz-Shouval Ruth
Published: April 2023

List of antibodies used in the study
Table S2 from An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer
Authors: Sharif Ghada M. , Campbell Moray J. , Nasir Apsra , Sengupta Surojeet , Graham Garrett T. , Kushner Max H. , Kietzman William B. , Schmidt Marcel O. , Pearson Gray W. , Loudig Olivier , Fineberg Susan , Wellstein Anton , Riegel Anna T.
Published: April 2023

A list of enriched pathways using Gene Set Enrichment Analysis (GSEA).
Supplementary Table S3 from A Combinatorial CRISPR–Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment
Authors: Xu Feng , Tong Man , Tong Cindy S.W. , Chan Becky K.C. , Chu Hoi Yee , Wong Tin Lok , Fong John H.C. , Cheung Maggie S.H. , Mak Kylie Hin-Man , Pardeshi Lakhansing , Huang Yuanhua , Wong Koon Ho , Choi Gigi C.G. , Ma Stephanie , Wong Alan S.L.
Published: April 2023

Supplementary Table S3
Table S4 from Exogenous and Endogenous Sources of Serine Contribute to Colon Cancer Metabolism, Growth, and Resistance to 5-Fluorouracil
Authors: Montrose David C. , Saha Suchandrima , Foronda Miguel , McNally Erin M. , Chen Justin , Zhou Xi Kathy , Ha Taehoon , Krumsiek Jan , Buyukozkan Mustafa , Verma Akanksha , Elemento Olivier , Yantiss Rhonda K. , Chen Qiuying , Gross Steven S. , Galluzzi Lorenzo , Dow Lukas E. , Dannenberg Andrew J.
Published: April 2023

Demographic information taken from the TCGA, of patients used for survival analysis shown in Supplementary Figure S1.
Figure S9 from Exogenous and Endogenous Sources of Serine Contribute to Colon Cancer Metabolism, Growth, and Resistance to 5-Fluorouracil
Authors: Montrose David C. , Saha Suchandrima , Foronda Miguel , McNally Erin M. , Chen Justin , Zhou Xi Kathy , Ha Taehoon , Krumsiek Jan , Buyukozkan Mustafa , Verma Akanksha , Elemento Olivier , Yantiss Rhonda K. , Chen Qiuying , Gross Steven S. , Galluzzi Lorenzo , Dow Lukas E. , Dannenberg Andrew J.
Published: April 2023

Supplementary Figure S9. Loss of exogenous and endogenous sources of serine induces a DNA damage response in DLD1 cells.
Supplementary Data from Engineering T Cells to Express Tumoricidal MDA-7/IL24 Enhances Cancer Immunotherapy
Authors: Liu Zheng , Guo Chunqing , Das Swadesh K. , Yu Xiaofei , Pradhan Anjan K. , Li Xia , Ning Yanxia , Chen Shixian , Liu Wenjie , Windle Jolene J. , Bear Harry D. , Manjili Masoud H. , Fisher Paul B. , Wang Xiang-Yang
Published: April 2023

Supplementary Figure S4. MDA-7/IL-24 engineering confers T cells with improved therapeutic activity in eradication of prostate cancer.
Supplementary File 2 from Network Analysis Identifies Regulators of Basal-Like Breast Cancer Reprogramming and Endocrine Therapy Vulnerability
Authors: Choi Sea R. , Hwang Chae Young , Lee Jonghoon , Cho Kwang-Hyun
Published: April 2023

Differentially expressed genes in basal-like and luminal-A patient samples of TCGA.